These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37108388)

  • 1. Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study.
    Müller P; Meta M; Meidner JL; Schwickert M; Meyr J; Schwickert K; Kersten C; Zimmer C; Hammerschmidt SJ; Frey A; Lahu A; de la Hoz-Rodríguez S; Agost-Beltrán L; Rodríguez S; Diemer K; Neumann W; Gonzàlez FV; Engels B; Schirmeister T
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising covalent warhead reactivity.
    Martin JS; MacKenzie CJ; Fletcher D; Gilbert IH
    Bioorg Med Chem; 2019 May; 27(10):2066-2074. PubMed ID: 30975501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophilic warheads in covalent drug discovery: an overview.
    Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
    Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method for filtering of reactive "warheads" of transition-state analog protease inhibitors.
    Traube T; Shokhen M; Albeck A
    Eur J Med Chem; 2014 Apr; 77():134-8. PubMed ID: 24631732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and
    Bai B; Belovodskiy A; Hena M; Kandadai AS; Joyce MA; Saffran HA; Shields JA; Khan MB; Arutyunova E; Lu J; Bajwa SK; Hockman D; Fischer C; Lamer T; Vuong W; van Belkum MJ; Gu Z; Lin F; Du Y; Xu J; Rahim M; Young HS; Vederas JC; Tyrrell DL; Lemieux MJ; Nieman JA
    J Med Chem; 2022 Feb; 65(4):2905-2925. PubMed ID: 34242027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.
    Brogi S; Ibba R; Rossi S; Butini S; Calderone V; Gemma S; Campiani G
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors.
    Bai B; Arutyunova E; Khan MB; Lu J; Joyce MA; Saffran HA; Shields JA; Kandadai AS; Belovodskiy A; Hena M; Vuong W; Lamer T; Young HS; Vederas JC; Tyrrell DL; Lemieux MJ; Nieman JA
    RSC Med Chem; 2021 Oct; 12(10):1722-1730. PubMed ID: 34778773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of Coronavirus 3C-Like protease (3CL
    Liu Y; Liang C; Xin L; Ren X; Tian L; Ju X; Li H; Wang Y; Zhao Q; Liu H; Cao W; Xie X; Zhang D; Wang Y; Jian Y
    Eur J Med Chem; 2020 Nov; 206():112711. PubMed ID: 32810751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Michael Acceptor-Based Peptidomimetic Inhibitor of Main Protease from Porcine Epidemic Diarrhea Virus.
    Wang F; Chen C; Yang K; Xu Y; Liu X; Gao F; Liu H; Chen X; Zhao Q; Liu X; Cai Y; Yang H
    J Med Chem; 2017 Apr; 60(7):3212-3216. PubMed ID: 28287727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Design of High-Affinity and Selective Peptidomimetic Hepsin Inhibitors.
    Knaff PM; Müller P; Kersten C; Wettstein L; Münch J; Landfester K; Mailänder V
    Biomacromolecules; 2022 Jun; 23(6):2236-2242. PubMed ID: 35593713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship study of peptidomimetic aldehydes as enterovirus 71 3C protease inhibitors.
    Zhai Y; Ma Y; Ma F; Nie Q; Ren X; Wang Y; Shang L; Yin Z
    Eur J Med Chem; 2016 Nov; 124():559-573. PubMed ID: 27614190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
    Ábrányi-Balogh P; Petri L; Imre T; Szijj P; Scarpino A; Hrast M; Mitrović A; Fonovič UP; Németh K; Barreteau H; Roper DI; Horváti K; Ferenczy GG; Kos J; Ilaš J; Gobec S; Keserű GM
    Eur J Med Chem; 2018 Dec; 160():94-107. PubMed ID: 30321804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking.
    Vázquez-Mendoza LH; Mendoza-Figueroa HL; García-Vázquez JB; Correa-Basurto J; García-Machorro J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease.
    Su H; Yao S; Zhao W; Zhang Y; Liu J; Shao Q; Wang Q; Li M; Xie H; Shang W; Ke C; Feng L; Jiang X; Shen J; Xiao G; Jiang H; Zhang L; Ye Y; Xu Y
    Nat Commun; 2021 Jun; 12(1):3623. PubMed ID: 34131140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease.
    Lim HA; Joy J; Hill J; San Brian Chia C
    Eur J Med Chem; 2011 Jul; 46(7):3130-4. PubMed ID: 21565434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases.
    Chuck CP; Chen C; Ke Z; Wan DC; Chow HF; Wong KB
    Eur J Med Chem; 2013 Jan; 59():1-6. PubMed ID: 23202846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanopyrrolidine Inhibitors of Ubiquitin Specific Protease 7 Mediate Desulfhydration of the Active-Site Cysteine.
    Bashore C; Jaishankar P; Skelton NJ; Fuhrmann J; Hearn BR; Liu PS; Renslo AR; Dueber EC
    ACS Chem Biol; 2020 Jun; 15(6):1392-1400. PubMed ID: 32302100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease.
    Hammamy MZ; Haase C; Hammami M; Hilgenfeld R; Steinmetzer T
    ChemMedChem; 2013 Feb; 8(2):231-41. PubMed ID: 23307694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease.
    Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure-Activity Relationship Insights and Evolution Perspectives.
    La Monica G; Bono A; Lauria A; Martorana A
    J Med Chem; 2022 Oct; 65(19):12500-12534. PubMed ID: 36169610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.